Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
6.81
+0.74 (12.19%)
At close: Aug 13, 2025, 4:00 PM
6.80
-0.01 (-0.15%)
Pre-market: Aug 14, 2025, 8:47 AM EDT
Mersana Therapeutics Market Cap
Mersana Therapeutics has a market cap or net worth of $33.95 million as of August 14, 2025. Its market cap has decreased by -86.79% in one year.
Market Cap
33.95M
Enterprise Value
-43.71M
1-Year Change
-86.79%
Ranking
Category
Stock Price
$6.81
Market Cap Chart
Since June 28, 2017, Mersana Therapeutics's market cap has decreased from $317.00M to $33.95M, a decrease of -89.29%. That is a compound annual growth rate of -24.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 30.30M | -82.85% |
| Dec 31, 2024 | 176.70M | -36.85% |
| Dec 29, 2023 | 279.80M | -52.15% |
| Dec 30, 2022 | 584.70M | 30.72% |
| Dec 31, 2021 | 447.30M | -75.46% |
| Dec 31, 2020 | 1.82B | 564.25% |
| Dec 31, 2019 | 274.40M | 190.06% |
| Dec 31, 2018 | 94.60M | -74.69% |
| Dec 29, 2017 | 373.80M | 17.92% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 589.81B |
| Johnson & Johnson | 419.05B |
| AbbVie | 355.43B |
| UnitedHealth Group | 245.27B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 226.29B |
| Novo Nordisk | 223.00B |